A growing number of patients are launching compensation claims against manufacturers of the heartburn medication Zantac. Claims against the drug center around potential links to cancer, leading to a flood of lawsuits. The federal government has also restricted the sale of Zantac, further fueling concerns about its safety. Law professionals predict